Rimegepant
CAS 1289023-67-1 1 API supplierSmall Molecule
Overview
Rimegepant is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2178422).
API suppliers (1)
Suppliers of Rimegepant evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Where these suppliers are
China1
- Porton Pharma Solutions Ltd.China1 active DMF
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Rimegepant expires 25 Mar 2039. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- [(5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl] 4-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate
- Canonical SMILES
- C1C[C@H](C2=C(C=CC=N2)[C@H]([C@@H]1C3=C(C(=CC=C3)F)F)N)OC(=O)N4CCC(CC4)N5C6=C(NC5=O)N=CC=C6
- InChIKey
- KRNAOFGYEFKHPB-ANJVHQHFSA-N
Verified Supplier Partner
Do you supply Rimegepant? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.